News

15 March 2021

BAP Pharma rank 78th in the Minority Supplier Development UK Report 2021

We are excited and proud to announce that BAP Pharma have ranked 78th in the Minority Supplier Development UK Report 2021 – the first ever list of the country’s top 100 minority businesses.

The Minority Supplier Development UK (MSDUK) is the UK’s premier not-for-profit membership organisation, championing diversity and inclusion in the public and private sector supply chains.

MSDUK collaborated with OPEN to produce exclusive new research and analysis, to develop the Minority Businesses Matter report, which highlights the importance and untapped potential of ethnic minority businesses.

Minority Supplier Development UK Report 2021

This landmark report aims to bring change to minority businesses contributions being overlooked by policymakers and the wider business community, by presenting fresh analysis of existing evidence on minority businesses.

Despite the challenges often faced, ethnic-minority entrepreneurs and businesses make a huge economic contribution to the UK, with minority businesses contributing at least £74 billion a year to the UK economy.

In 2019-20, minority businesses contributed gross value added of at least £74 billion, £47.9 billion in employee compensation, £4.7 billion in corporation tax payments and £21.4 billion in post-tax profits.

“We are extremely proud to be recognised in the first ever list of the country’s top 100 minority businesses, for our efforts to champion diversification within BAP Pharma. This would not have been possible without the support from our clients, who recognise diversity as an essential part of their culture and our diverse workforce”.

Dr. Bashir Pakar, Founder and Managing Director of BAP Pharma.

BAP Pharma’s rankings in the Minority Supplier Development UK Report 2021:

Ranked 78th in The MSDUK-OPEN Top 100 Minority Businesses 2019-20
Ranked 9th in the Top 10 Minority Businesses with the Highest Foreign Sales as a percentage of turnover 2019-20
Ranked 8th in the Top 10 Minority Pharmaceutical Business by turnover 2019-20

You Might Also Like

BAP Pharma Granted Secondary Packaging and Labelling Licence

BAP Pharma are pleased to announce that the Government of Upper Bavaria (Regierung von Oberbayern) have granted a Secondary Packaging and Labelling licence, to our German facility. The new licence will enable BAP Pharma to offer bespoke Clinical Trial Secondary Packaging and Labelling services, to complement our award-winning Comparator Sourcing

BAP Pharma Granted Secondary Packaging and Labelling Licence

Walk All Over Cancer Challenge 2021

At the beginning of March 2021, a group of volunteers came together from BAP Pharma Ltd, to form the BAP Steppers. Their aim – to take on the Walk All Over Cancer challenge for Cancer Research UK. The BAP Steppers put on their walking shoes and braved the unpredictable weather,

Walk All Over Cancer Challenge 2021

BAP Pharma awarded EcoVadis Silver Sustainability Rating

BAP Pharma are excited and proud to announce that we have achieved a Silver rating in the recent EcoVadis Sustainability ratings, placing the company within the 90th percentile of all rated companies worldwide. EcoVadis review more than 75,000 companies based on four main areas: Environment Labour & Human Rights Ethics

BAP Pharma awarded EcoVadis Silver Sustainability Rating